231 related articles for article (PubMed ID: 33402118)
1. Role of long non-coding RNA H19 in therapy resistance of digestive system cancers.
Wang J; Ma X; Si H; Ma Z; Ma Y; Wang J; Cao B
Mol Med; 2021 Jan; 27(1):1. PubMed ID: 33402118
[TBL] [Abstract][Full Text] [Related]
2. Long Noncoding RNA H19 in Digestive System Cancers: A Meta-Analysis of Its Association with Pathological Features.
Lin Y; Xu L; Wei W; Zhang X; Ying R
Biomed Res Int; 2016; 2016():4863609. PubMed ID: 27738631
[TBL] [Abstract][Full Text] [Related]
3. Long non-coding RNA H19, a novel therapeutic target for pancreatic cancer.
Wang J; Zhao L; Shang K; Liu F; Che J; Li H; Cao B
Mol Med; 2020 Apr; 26(1):30. PubMed ID: 32272875
[TBL] [Abstract][Full Text] [Related]
4. Critical Functions of lncRNA DGCR5 in Cancers of the Digestive System.
Hu C; Xu W; Wang B; Chen J; Zhou Z; Zhou G; Yuan C
Curr Pharm Des; 2021; 27(40):4147-4151. PubMed ID: 34387158
[TBL] [Abstract][Full Text] [Related]
5. Correlation of long non-coding RNA H19 expression with cisplatin-resistance and clinical outcome in lung adenocarcinoma.
Wang Q; Cheng N; Li X; Pan H; Li C; Ren S; Su C; Cai W; Zhao C; Zhang L; Zhou C
Oncotarget; 2017 Jan; 8(2):2558-2567. PubMed ID: 27911863
[TBL] [Abstract][Full Text] [Related]
6. LncRNA H19/miR-194/PFTK1 axis modulates the cell proliferation and migration of pancreatic cancer.
Sun Y; Zhu Q; Yang W; Shan Y; Yu Z; Zhang Q; Wu H
J Cell Biochem; 2019 Mar; 120(3):3874-3886. PubMed ID: 30474270
[TBL] [Abstract][Full Text] [Related]
7. Long non-coding small nucleolar RNA host genes in digestive cancers.
Yang H; Jiang Z; Wang S; Zhao Y; Song X; Xiao Y; Yang S
Cancer Med; 2019 Dec; 8(18):7693-7704. PubMed ID: 31691514
[TBL] [Abstract][Full Text] [Related]
8. Long noncoding RNA H19 participates in metformin-mediated inhibition of gastric cancer cell invasion.
Li P; Tong L; Song Y; Sun J; Shi J; Wu Z; Diao Y; Li Y; Wang Z
J Cell Physiol; 2019 Apr; 234(4):4515-4527. PubMed ID: 30192003
[TBL] [Abstract][Full Text] [Related]
9. Long noncoding RNA H19 promotes chemotherapy resistance in choriocarcinoma cells.
Yu S; Wu C; Tan Q; Liu H
J Cell Biochem; 2019 Sep; 120(9):15131-15144. PubMed ID: 31020694
[TBL] [Abstract][Full Text] [Related]
10. Long noncoding RNA H19 acts as a miR-340-3p sponge to promote epithelial-mesenchymal transition by regulating YWHAZ expression in paclitaxel-resistant breast cancer cells.
Yan L; Yang S; Yue CX; Wei XY; Peng W; Dong ZY; Xu HN; Chen SL; Wang WR; Chen CJ; Yang QL
Environ Toxicol; 2020 Sep; 35(9):1015-1028. PubMed ID: 32420678
[TBL] [Abstract][Full Text] [Related]
11. LncRNA H19 confers chemoresistance in ERα-positive breast cancer through epigenetic silencing of the pro-apoptotic gene BIK.
Si X; Zang R; Zhang E; Liu Y; Shi X; Zhang E; Shao L; Li A; Yang N; Han X; Pan B; Zhang Z; Sun L; Sun Y
Oncotarget; 2016 Dec; 7(49):81452-81462. PubMed ID: 27845892
[TBL] [Abstract][Full Text] [Related]
12. Role of non-coding RNAs and RNA modifiers in cancer therapy resistance.
Zhang X; Xie K; Zhou H; Wu Y; Li C; Liu Y; Liu Z; Xu Q; Liu S; Xiao D; Tao Y
Mol Cancer; 2020 Mar; 19(1):47. PubMed ID: 32122355
[TBL] [Abstract][Full Text] [Related]
13. Expression and role of long non-coding RNA H19 in carcinogenesis.
Yoshimura H; Matsuda Y; Yamamoto M; Kamiya S; Ishiwata T
Front Biosci (Landmark Ed); 2018 Jan; 23(4):614-625. PubMed ID: 28930564
[TBL] [Abstract][Full Text] [Related]
14. Prognostic value of long non-coding RNA ATB in digestive system cancers: A meta-analysis.
Cheng XB; Fu B; Li XZ; Jiang Y
Pathol Res Pract; 2020 Jun; 216(6):152949. PubMed ID: 32307201
[TBL] [Abstract][Full Text] [Related]
15. Emerging role of long non-coding RNAs in cancer chemoresistance: unravelling the multifaceted role and prospective therapeutic targeting.
Singh D; Khan MA; Siddique HR
Mol Biol Rep; 2020 Jul; 47(7):5569-5585. PubMed ID: 32601922
[TBL] [Abstract][Full Text] [Related]
16. Long non-coding RNA H19 confers resistance to gefitinib via miR-148b-3p/DDAH1 axis in lung adenocarcinoma.
Huang Z; Ma Y; Zhang P; Si J; Xiong Y; Yang Y
Anticancer Drugs; 2020 Jan; 31(1):44-54. PubMed ID: 31503013
[TBL] [Abstract][Full Text] [Related]
17. Long non-coding RNA (lncRNA) H19 in human cancer: From proliferation and metastasis to therapy.
Hashemi M; Moosavi MS; Abed HM; Dehghani M; Aalipour M; Heydari EA; Behroozaghdam M; Entezari M; Salimimoghadam S; Gunduz ES; Taheriazam A; Mirzaei S; Samarghandian S
Pharmacol Res; 2022 Oct; 184():106418. PubMed ID: 36038043
[TBL] [Abstract][Full Text] [Related]
18. The role of H19 lncRNA in conferring chemoresistance in cancer cells.
Ghafouri-Fard S; Shoorei H; Bahroudi Z; Abak A; Taheri M
Biomed Pharmacother; 2021 Jun; 138():111447. PubMed ID: 33667788
[TBL] [Abstract][Full Text] [Related]
19. The Interaction Between MiR-141 and lncRNA-H19 in Regulating Cell Proliferation and Migration in Gastric Cancer.
Zhou X; Ye F; Yin C; Zhuang Y; Yue G; Zhang G
Cell Physiol Biochem; 2015; 36(4):1440-52. PubMed ID: 26160158
[TBL] [Abstract][Full Text] [Related]
20. Long non-coding RNA H19 promotes colorectal cancer metastasis via binding to hnRNPA2B1.
Zhang Y; Huang W; Yuan Y; Li J; Wu J; Yu J; He Y; Wei Z; Zhang C
J Exp Clin Cancer Res; 2020 Jul; 39(1):141. PubMed ID: 32698890
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
